Xconomy National

by in

Entry	Author	Date	Location
Pathway Medical Grinds It Out, Seeks Profit Formula, Three Years After FDA Approval	Luke Timmerman	06/08/11	Seattle
Pervasis in “Advanced” Talks with Potential Partners for Blood-Vessel Healing Product, CEO Says	Ryan McBride	02/01/11	Boston
Aastrom Gets FDA Fast Track Status, Gears Up for Pivotal Study of Cell Therapy	Luke Timmerman	10/18/10	Detroit
Covidien to Buy Ev3 for $2.6B	Ryan McBride	06/01/10	Boston
Pathway Medical Learns Lessons During Tougher Than Expected First Year on Market	Luke Timmerman	10/20/09	Seattle
Minnow Medical Aims to Commercialize Improved Device for Treating Peripheral Artery Disease	Bruce V. Bigelow	09/09/09	San Diego
Genzyme Gene Therapy Fails To Help People with Leg Disease Walk Longer	Luke Timmerman	03/31/09	Boston
Pathway Medical Raises $40M for Device to Clear Out Blocked Leg Arteries	Luke Timmerman	03/26/09	Seattle
Sticking to its Guns with Gene Therapy, Genzyme To Present Key Findings Within Days	Luke Timmerman	03/25/09	Boston
Pathway Medical Tool Shows Early Signs of Emerging as “Real Winner”	Luke Timmerman	02/02/09	Seattle
Pathway Medical, With FDA Clearance in Hand, Starts Selling Device for Wiping Out Blockages in Leg Arteries	Luke Timmerman	09/05/08	Seattle
Pathway Wins FDA Approval To Sell Blocked-Artery Buster	Luke Timmerman	07/21/08	Seattle
Page 1 of 1